Vasopressin therapy in Parkinson's disease
- 1 September 1980
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 62 (3) , 197-199
- https://doi.org/10.1111/j.1600-0404.1980.tb03024.x
Abstract
A double‐blind crossover pilot study was carried out in six patients with Parkinson's disease in order to test the possible therapeutic effect of L‐vasopressin after treatment for 1 month with 30 I.U. intranasally daily. The investigation was completed in five cases. No effect was noticed after LVP treatment.Keywords
This publication has 5 references indexed in Scilit:
- Neurohypophyseal principles and memory processesBiochemical Pharmacology, 1978
- VASOPRESSIN IN AFFECTIVE ILLNESSThe Lancet, 1978
- Arginine8-vasopressin affects catecholamine metabolism in specific brain nucleiLife Sciences, 1977
- Neuropharmacology of hypothalamic releasing factorsBiochemical Pharmacology, 1976
- Hypothalamic Releasing Factors and Parkinson DiseaseArchives of Neurology, 1974